Literature DB >> 10349065

How patient outcomes are reported in drug advertisements.

J Lexchin1.   

Abstract

OBJECTIVE: To examine how changes in outcomes are reported in drug advertisements in medical journals. QUALITY OF EVIDENCE: Advertisements from a convenience sample of 38 issues of Canadian Family Physician, Canadian Journal of Anaesthesia, Canadian Journal of Psychiatry, Canadian Medical Association Journal, and the New England Journal of Medicine. MAIN MESSAGE: Method of reporting changes in clinical outcomes (relative risk reduction [RRR], absolute risk reduction [ARR], number needed to treat [NNT]), name of product, and company marketing product were sought. In the 22 advertisements included in the analysis, 11 reported results as RRRs; two reported results as RRRs, but readers could calculate ARRs or NNTs from figures given in the advertisement; and nine gave no measure of results, but readers could calculate RRRs, ARRs, or NNTs from figures given.
CONCLUSIONS: Most companies report changes in outcomes as RRRs, and this bias could influence the way physicians prescribe. Changes to the rules governing journal advertising and increased emphasis on critical appraisal skills would help mitigate this bias.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10349065      PMCID: PMC2328571     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  2 in total

1.  Completeness of reporting trial results: effect on physicians' willingness to prescribe.

Authors:  M Bobbio; B Demichelis; G Giustetto
Journal:  Lancet       Date:  1994-05-14       Impact factor: 79.321

2.  Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness?

Authors:  C D Naylor; E Chen; B Strauss
Journal:  Ann Intern Med       Date:  1992-12-01       Impact factor: 25.391

  2 in total
  6 in total

1.  Keeping pharmaceutical advertising on track.

Authors:  R Chepesiuk
Journal:  Can Fam Physician       Date:  1999-07       Impact factor: 3.275

2.  Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States.

Authors:  Noordin Othman; Agnes I Vitry; Elizabeth E Roughead
Journal:  BMC Public Health       Date:  2010-05-29       Impact factor: 3.295

3.  Evaluation of rationality of promotional drug literature using World Health Organization guidelines.

Authors:  Smita N Mali; Sujata Dudhgaonkar; N P Bachewar
Journal:  Indian J Pharmacol       Date:  2010-10       Impact factor: 1.200

4.  Adherence of pharmaceutical advertisements in medical journals to FDA guidelines and content for safe prescribing.

Authors:  Deborah Korenstein; Salomeh Keyhani; Ali Mendelson; Joseph S Ross
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

Review 5.  Quality of pharmaceutical advertisements in medical journals: a systematic review.

Authors:  Noordin Othman; Agnes Vitry; Elizabeth E Roughead
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

6.  Clinician Conceptualization of the Benefits of Treatments for Individual Patients.

Authors:  Daniel J Morgan; Lisa Pineles; Jill Owczarzak; Larry Magder; Laura Scherer; Jessica P Brown; Chris Pfeiffer; Chris Terndrup; Luci Leykum; David Feldstein; Andrew Foy; Deborah Stevens; Christina Koch; Max Masnick; Scott Weisenberg; Deborah Korenstein
Journal:  JAMA Netw Open       Date:  2021-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.